Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/05/2016 12/06/2016 12/07/2016 12/08/2016 12/09/2016 Date
13.28(c) 13.69(c) 12.76(c) 12.98(c) 12.68(c) Last
5 012 126 4 394 411 9 396 544 4 345 658 4 335 949 Volume
+0.91% +3.09% -6.79% +1.72% -2.31% Change
More quotes
Financials ($)
Sales 2016 196 M
EBIT 2016 -112 M
Net income 2016 -7,71 M
Debt 2016 152 M
Yield 2016 -
Sales 2017 234 M
EBIT 2017 -59,9 M
Net income 2017 -107 M
Debt 2017 183 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 13,4x
EV / Sales2017 11,3x
Capitalization 2 462 M
More Financials
Company
ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.Its products include Iclusig and Caregivers.The company was founded by Harvey J. Berger in April 1991 and is... 
More about the company
Surperformance© ratings of Ariad Pharmaceuticals, Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ARIAD PHARMACEUTICALS, INC
12/08 ARIAD PHARMACEUTICALS : Announces FDA Full Approval and Label Update for Iclusig..
12/08 ARIAD PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (for..
12/07 ARIAD PHARMACEUTICALS INC : Change in Directors or Principal Officers, Financial..
12/07 ARIAD PHARMACEUTICALS : ARIADs Investigational Medicine Brigatinib Demonstrated ..
12/07 ARIAD PHARMACEUTICALS : Investigational Medicine Brigatinib Demonstrated 15.6 Mo..
12/06 ARIAD PHARMACEUTICALS : Announces Data Presentations at American Society of Hema..
12/05 ARIAD PHARMACEUTICALS : Presents Updated Brigatinib Data with 18.4 Months Median..
12/02 ARIAD PHARMACEUTICALS : to Host Webcast and Conference Call on Brigatinib Data P..
12/02 BEST BIOTECH STOCKS 2016 : The NASDAQ’s Top-Performers
11/30 ARIAD PHARMACEUTICALS, INC. (N : ARIA) Files An 8-K Other Events
More news
Sector news : Bio Therapeutic Drugs
12/03DJJOHNSON & JOHNSON : Boosts Actelion Bid -Bloomberg
12/02 Pharma execs weigh in on possible changes under Trump
11/30 ACTELION : Rejecting J&J could leave Actelion with 'lot of explaining to do'
11/28 Actelion's ambitious independent-minded CEO will drive up takeover price
11/26DJWHAT'S NEWS : Business & Finance -- WSJ
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
12/09 They're Definitely High On Something
12/07 ARIAD's brigatinib stops lung cancer progression for almost 16 months in mid-..
12/05 ARIAD : The Storm Has Passed
11/29 FDA fully approves ARIAD's Iclusig and a label update to include four-year fo..
11/29 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
Advertisement
Chart ARIAD PHARMACEUTICALS, INC
Duration : Period :
Ariad Pharmaceuticals, Inc Technical Analysis Chart | ARIA | US04033A1007 | 4-Traders
Full-screen chart
Technical analysis trends ARIAD PHARMACEUTI...
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 13,5 $
Spread / Average Target 6,1%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Paris Panayiotopoulos President, Chief Executive Officer & Director
Alexander John Denner Chairman
Manmeet Singh Soni Chief Financial Officer, Treasurer & Executive VP
Timothy P. Clackson Chief Scientific Officer
Nicholas Ventresca Chief Information Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ARIAD PHARMACEUTICALS,..102.88%2 462
AMGEN, INC.-11.63%106 716
GILEAD SCIENCES, INC.-28.16%95 779
CELGENE CORPORATION-5.25%87 962
REGENERON PHARMACEUTIC..-31.32%39 322
ACTELION LTD50.21%22 204
More Results